Retinoids and teratogenicity.
Jick
H
H
Boston Collaborative Drug Surveillance Program, Boston University Medical Center, Lexington, Massachusetts 02173, USA.
D000014:Abnormalities, Drug-Induced / Q000453:epidemiology / Q000209:etiology*; D016022:Case-Control Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000009:adverse effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology; D011297:Prenatal Exposure Delayed Effects; D012176:Retinoids / Q000009:adverse effects*; D014212:Tretinoin / Q000009:adverse effects; D014801:Vitamin A / Q000008:administration & dosage / Q000009:adverse effects
D007641:Keratolytic Agents; D012176:Retinoids; D014801:Vitamin A; D014212:Tretinoin